Baseline PET Metabolic Tumor Volume Predicts Outcome in Advanced Follicular Lymphoma Patients Who Received First-Line Immunochemotherapy but Not Those Treated with Lenalidomide-Rituximab in the Phase III Relevance Study

Saved in:
Bibliographic Details
Published inBlood Vol. 140; no. Supplement 1; pp. 6474 - 6476
Main Authors Cottereau, Anne Ségolène, Rebaud, Louis, Trotman, Judith, Feugier, Pierre, Nastoupil, Loretta J., Bachy, Emmanuel, Flinn, Ian W., Haioun, Corinne, Ysebaert, Loic, Bartlett, Nancy L., Tilly, Hervé, Casasnovas, René-Olivier, Ricci, Romain, Portugues, Cedric, Buvat, Irène, Meignan, Michel, Morschhauser, Franck
Format Journal Article
LanguageEnglish
Published Elsevier Inc 15.11.2022
Online AccessGet full text

Cover

More Information
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-159207